Picture of Biotricity logo

BTCY — Biotricity News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Biotricity Inc expected to post a loss of 7 cents a share - Earnings Preview

* Biotricity Inc  BTCY.OQ   BTCY.O  is expected to show a
rise in
quarterly revenue when it reports  results on November 14. 
    * The Redwood City California-based  company is expected to
report
 a 40.5% increase in revenue to $2.539 million from $1.81
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Biotricity Inc is
for a
loss of 7 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Biotricity
Inc is
$3​, above​ its last closing price of $1.02. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.12       -0.11      -0.10     Beat    13
 Mar. 31 2022              -0.11      -0.11     Met     0
 Dec. 31 2021  -0.17       -0.16      -0.12     Beat    27.3​
 Sep. 30 2021  -0.11       -0.10      -0.14     Missed  -40
 ​​Jun.        -0.09       -0.09      -0.09     Met     0
 30 2021                                                
                                                        ​
 This summary was machine generated November 11 at 22:40 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on Biotricity

See all news